Phoenix Solutions AS completes its Series A financing.

The Board of Directors of Phoenix Solutions is pleased to announce that the company has completed a series A financing led by a small group of healthcare angel investors. CEO Per Sontum; "We are very pleased to announce this first round of financing. This funding will give us the ability to reach a key developmental milestone for our preclinical work in pancreatic cancer ".

Previous
Previous

Targeted drug delivery platform company Phoenix Solutions AS is awarded 16 MNoK (1.8 M€) from the Research Council of Norway.

Next
Next

A Journal paper and cover story on ACT have been published.